Shanghai company unveils simultaneous COVID-19 and flu test kit

Researchers work in a lab of Shanghai-based 3DMed Diagnostics. (Photo: China Daily) Developed by a local biotech company, a testing kit that is able to screen individuals for both the novel coronavirus and the influenza virus at once was granted market approval by the National Medical Products Administration. The nucleic acid testing kit by 3DMed Diagnostics, a Shanghai-based medical testing solutions provider, is the first of its kind in the country to function based on fluorescence quantitative PCR platform, the Shanghai Science and Technology Commission said on Aug 19 following the product’s market approval on Aug 16. Experts explained patients…